Provectus Biopharmaceuticals
www.provectusbio.comProvectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
Read more
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
Read more
Country
State
Tennessee
City (Headquarters)
Knoxville
Industry
Employees
1-10
Founded
2004
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chairman of the Board
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Global Director of Clinical Operations
Email ****** @****.comPhone (***) ****-****Clinical Operations Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(10)
Reach decision makers at Provectus Biopharmaceuticals
Free credits every month!
Provectus Biopharmaceuticals FAQ
Knoxville, United States
Biotechnology Research
